Stanislav Katina

Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial

Petr Novák, Reinhold Schmidt, Eva Kontseková et al. · The Lancet Neurology · 2016 · 302 citations

Medicine, Immunology, Neurology +12

ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease

Petr Novák, Branislav Kováčech, Stanislav Katina et al. · Nature Aging · 2021 · 172 citations · Full text

Life Sciences, Neurology, Neuroscience +15

Assessment of severity and progression of canine cognitive dysfunction syndrome using the CAnine DEmentia Scale (CADES)

Aladár Maďari, Jana Farbáková, Stanislav Katina et al. · Applied Animal Behaviour Science · 2015 · 151 citations

Medicine, Neurology, Neuroscience +14

FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease

Petr Novák, Reinhold Schmidt, Eva Kontseková et al. · Alzheimer s Research & Therapy · 2018 · 143 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +17

Cues to fertility: perceived attractiveness and facial shape predict reproductive success

Lena S. Pflüger, Elisabeth Oberzaucher, Stanislav Katina et al. · Evolution and Human Behavior · 2012 · 114 citations

Social Sciences, Psychology, Evolutionary Psychology +13